Eir Accelerator: Finland’s Free Women’s Health Startup Program Opens Applications
Women’s health has long been the most underfunded, under-researched corner of medtech. Finland just made a serious, structural move to change that — building a programme with reach across Europe and beyond from day one.
Eir Accelerator, a six-month hybrid programme dedicated entirely to women’s health innovation, has officially opened applications to founders anywhere in the world.
Rooted in Turku — one of Europe’s densest life-science clusters — and coordinated by Business Turku, the programme is free to join, takes no equity, and gives founders something rarer than cash: direct access to pharma partners, clinical biobanks, and a genuinely international investor bench.
What Is Eir Accelerator?
Named after Eir, the Norse goddess of healing, Eir Accelerator is the accelerator arm of Women’s Health Hub Finland. It’s a free, hybrid, 6-month programme built exclusively for startups working in women’s health — defined broadly as any condition that affects women disproportionately, differently, or exclusively, from endometriosis and menopause to cardiovascular and brain health.
The scale of the opportunity is central to the pitch: better care for just ten conditions — from menopause and PMS to heart disease and ovarian cancer — could unlock more than $500 billion in global GDP, part of a broader $1 trillion annual opportunity organisers expect to materialise by 2040.
At a national level, organisers estimate that serious investment in women’s health could add roughly €4.76 billion to Finland’s economy, with close to €3.9 billion in additional exports annually.
Why Turku, Finland?
Turku isn’t a random choice of base. The city is home to roughly half of Finland’s pharmaceutical and diagnostics sector and hosts more than 100 life-science companies — a density most European innovation hubs would envy. That infrastructure includes access to Finland’s biobank network (via FinBB), clinical research capacity, and a tight-knit university-hospital ecosystem spanning the University of Turku, Aalto University, the University of Helsinki, and Helsinki University Hospital (HUS).
Who’s Behind Eir Accelerator
Eir is led by Anastasiya Markvarde, Head of Eir Accelerator, who brings deep women’s health and program-building experience, alongside Minna Arve, CEO of Business Turku and former Mayor of the city. This pairing combines domain depth with direct access to Finland’s life-science infrastructure. The extended team draws on Women’s Health Hub Finland and Turku Startup Hub.
Jessica Federer, former Chief Digital Officer at Bayer and founder of The Women’s Health Fund, advises the programme directly, alongside mentors from organisations including Bayer and Mount Sinai.
What Founders Get From the Program
Eir runs a selective process with a limited number of teams per cohort, favouring substance over volume. Support is tailored by startup stage:
- Early-stage teams (pre-seed, spinouts, early MVP): help validate product-market fit, access data and biobank assets, design for clinical credibility, and build fundraising readiness.
- Later-stage teams — including those who assume they’re “too late” for a typical accelerator: support structuring pilots and sales into pharma and hospital partners, navigating EU MDR, the AI Act, and FDA pathways, plus warm introductions to investors for active rounds.
Selected teams also get stage presence at Eir events, a side event at Slush, Demo Day visibility, and a series of media interviews — plus the programme runs entirely free, with no application fee and no equity taken.
Eir Accelerator’s Partners and Investors: A Pan-European, Global Network
The wider ecosystem is genuinely heavyweight and international, extending well beyond Finland’s borders. Industry and academic partners include BioInnovation Institute, Bayer, Organon, Orion, Revvity, the University of Turku, Aalto University, University of Helsinki, Helsinki University Hospital (HUS), Metropolia University of Applied Sciences, the New Children’s Hospital in Helsinki, Turku Diagnostics, Hehku — and Tech4Fem, Italy’s femtech network, which places the Italian women’s health ecosystem directly inside Eir’s partner map.
On the capital side, 13 investment firms joined within the programme’s first month alone, spanning Finland, wider Europe, and beyond:
- Innovestor (Finland)
- Voima Ventures (Finland)
- Inventure (Finland)
- Amboy Street Ventures
- Angelini Ventures (Italy)
- Calm/Storm (Austria)
- Panakes Partners (Italy)
- Heal Capital (Germany)
- Mount Sinai Ventures (U.S.)
- Verge HealthTech Fund (Singapore)
- Suncoast Ventures (U.S.)
- Eir Ventures
- Fund F
- The Women’s Health Fund (Jessica Federer)
That mix — Italy, Austria, Germany, Singapore, and the U.S. alongside the Finnish core — is a fair signal of how deliberately international Eir’s investor bench is, rather than a Nordic-only network with a token outside name. Eir is also part of the Milken Institute Women’s Health Network — a global coalition of 170+ organisations — and Femtech Across Borders.
How to Apply to Eir Accelerator
Applications for Cohort 1 are open on a rolling basis, with the programme launching alongside Slush in Helsinki on November 18, 2026 — putting admitted founders on one of the most visible stages in the Nordic startup calendar from day one.
- Startups building in women’s health can apply directly at eir-accelerator.com
- Investors interested in the space can apply to join the network
- Partners and organisations (pharma, hospitals, universities, ecosystem builders) can apply to collaborate
Why This Matters Now
Given how thin the pipeline of dedicated, well-resourced women’s health accelerators still is globally — and how genuinely pan-European and international Eir’s partner and investor network already is — this is worth pushing into founder networks across Europe, not just reading about.
FAQ
Is Eir Accelerator free? Yes. Eir Accelerator takes no application fee and no equity from participating startups.
Who can apply to Eir Accelerator? Founders anywhere in the world working on women’s health — defined as any condition affecting women disproportionately, differently, or exclusively — can apply, regardless of stage.
When does the first cohort start? Cohort 1 launches on November 18, 2026, alongside a side event at Slush in Helsinki.
Where is Eir Accelerator based? Turku, Finland, home to roughly half of the country’s pharmaceutical and diagnostics sector.
Sources: Eir Accelerator, Femtech Insider
Editorial note: AI tools were used to help structure and edit the raw source material into this article format.
0 comments